Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study
JMIR Public Health and Surveillance · 2024
DOI: 10.2196/57290 ↗At a glance
Kohortenstudie in JMIR Public Health and Surveillance, 2024. Written by Jhaqueline Valle and 3 co-authors. Institution: Tracking California, Public Health Institute, Oakland, CA, United States. Major MEDLINE topics: Medicaid, Anemia, Sickle Cell, Renal Insufficiency, Chronic, Health Services Accessibility. Cited 4 times so far (Crossref); 30 references. The full text is freely available in PubMed Central. Funded by: NCBDD CDC HHS.
Abstract (original language)
Background
Chronic kidney disease (CKD) is a significant complication in patients with sickle cell disease (SCD), leading to increased mortality.
Objective
This study aims to investigate the burden of CKD in Medicaid-enrolled adults with SCD in California, examine differences in disease burden between male and female individuals, and assess mortality rates and access to specialized care.
Methods
This retrospective cohort study used the California Sickle Cell Data Collection program to identify and monitor individuals with SCD. Medicaid claims, vital records, emergency department, and hospitalization data from 2011 to 2020 were analyzed. CKD prevalence was assessed based on ICD (International Classification of Diseases) codes, and mortality rates were calculated. Access to specialized care was examined through outpatient encounter rates with hematologists and nephrologists.
Results
Among the 2345 adults with SCD, 24.4% (n=572) met the case definition for CKD. The SCD-CKD group was older at the beginning of this study (average age 44, SD 14 vs 34, SD 12.6 years) than the group without CKD. CKD prevalence increased with age, revealing significant disparities by sex. While the youngest (18-29 years) and oldest (>65 years) groups showed similar CKD prevalences between sexes (female: 12/111, 10.8% and male: 12/101, 11.9%; female: 74/147, 50.3% and male: 34/66, 51.5%, respectively), male individuals in the aged 30-59 years bracket exhibited significantly higher rates than female individuals (30-39 years: 49/294, 16.7%, P=.01; 40-49 years: 52/182, 28.6%, P=.02; and 50-59 years: 76/157,48.4%, P
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Tracking California, Public Health Institute, Oakland, CA, United States.
- Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, United States.
- Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego, San Diego, CA, United States.
- Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, CA, United States.
ORCID profiles: Jhaqueline Valle, Jeffrey D Lebensburger, Pranav S Garimella, Srila Gopal
Funding
- NCBDD CDC HHS
Cite
APA
Valle, J., Lebensburger, J. D., Garimella, P. S., & Gopal, S. (2024). Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study. JMIR Public Health and Surveillance. https://doi.org/10.2196/57290
Vancouver
Valle J, Lebensburger JD, Garimella PS, Gopal S. Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study. JMIR Public Health and Surveillance. 2024. doi:10.2196/57290
BibTeX
@article{Valle2024,
author = {Valle, Jhaqueline and Lebensburger, Jeffrey D and Garimella, Pranav S and Gopal, Srila},
title = {Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study},
journal = {JMIR Public Health and Surveillance},
year = {2024},
doi = {10.2196/57290}
}
EUVIMED